This occurs through several mechanisms such as downregulation of the antigen presentation machinery, loss of IFN-γ sensitivity, neoantigen depletion, tumor-mediated immunosuppression, and the expression of other inhibitory checkpoints (Schoenfeld and Hellmann, 2020). The gene discussed is IFNG; the disease is neoplasm.